UNAIDS warns of a global HIV crisis as U.S. funding cuts disrupt health programs, risking millions of lives and reversing decades of progress in the fight against AIDS ...

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said ...

The universe will not last forever. In fact, scientists have revealed that its lifespan is almost half over already.

Since 1995, National HIV Testing Day has raised awareness and confronted stereotypes about HIV. Learn about HIV testing options and prevention methods.

The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, following an outcry from HIV prevention organizations, health experts ...

MIT's new dual-adjuvant vaccine offers strong HIV protection with a single dose, potentially aiding in the fight against challenging viruses.

Gilead’s daily antiviral pills can prevent HIV transmission and slow AIDS. While an HIV vaccine remains the Holy Grail, Gilead’s new long-lasting injection, lenacapavir, is the next best thing.

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...